1. Ayurvedic medicines: cases of lead poisoning in New Zealand

   News item 16 March 2024 Pages: 1 - 1

2. Colistin-related risk of pseudo-Bartter syndrome

   News item 16 March 2024 Pages: 2 - 2

3. Dacarbazine in utero toxicity risk requires extended contraception

   News item 16 March 2024 Pages: 3 - 3

4. Illegal supply and use of prescription-only botulinum toxin

   News item 16 March 2024 Pages: 4 - 4

5. ISMP 2024-2025 best practices to reduce medication errors

   News item 16 March 2024 Pages: 5 - 5

6. One lot of Pediatrix Acetaminophen Oral Solution recalled in Canada

   News item 16 March 2024 Pages: 6 - 6

7. Prescribed Z-drugs may cause complex sleep behaviours and injuries

   News item 16 March 2024 Pages: 7 - 7

8. TGA initiates consultation on the compounding of GLP-1 RAs

   News item 16 March 2024 Pages: 8 - 8

9. Tramadol-related tinnitus

   News item 16 March 2024 Pages: 9 - 9

10. ED visits for unsupervised melatonin use in infants and children

    Clinical study 16 March 2024 Pages: 10 - 10

11. Preoperative glucocorticoids increase risk of SIRS after nephrolithotomy

    Clinical study 16 March 2024 Pages: 11 - 11

12. Risk of DVT higher with drospirenone/EE than with norethindrone/EE

    Clinical study 16 March 2024 Pages: 12 - 12

13. Other adverse reaction research

    News item 16 March 2024 Pages: 13 - 13

14. Abiraterone/docetaxel/prednisolone

    Case report 16 March 2024 Pages: 14 - 14

15. Aciclovir

    Case report 16 March 2024 Pages: 15 - 15

16. Aciclovir

    Case report 16 March 2024 Pages: 16 - 16

17. Acitretin/methotrexate

    Case report 16 March 2024 Pages: 17 - 17

18. Ad26.COV2-S/Adalimumab/Elasomeran

    Case report 16 March 2024 Pages: 18 - 18

19. Adalimumab

    Case report 16 March 2024 Pages: 19 - 19

20. Adalimumab

    Case report 16 March 2024 Pages: 20 - 20

21. Adenosine/Hydrochlorothiazide

    Case report 16 March 2024 Pages: 21 - 21

22. Aflibercept

    Case report 16 March 2024 Pages: 22 - 22

23. Albendazole/dexamethasone/ivermectin

    Case report 16 March 2024 Pages: 23 - 23

24. Albendazole/Prednisone

    Case report 16 March 2024 Pages: 24 - 24

25. Alcohol

    Case report 16 March 2024 Pages: 25 - 25

26. Alemtuzumab/corticosteroids/immunosuppressants

    Case report 16 March 2024 Pages: 26 - 26

27. Ambrisentan/sildenafil/treprostinil

    Case report 16 March 2024 Pages: 27 - 27

28. Amikacin/ciprofloxacin

    Case report 16 March 2024 Pages: 28 - 28

29. Amiodarone

    Case report 16 March 2024 Pages: 29 - 29

30. Amiodarone

    Case report 16 March 2024 Pages: 30 - 30

31. Amlodipine/Bisoprolol

    Case report 16 March 2024 Pages: 31 - 31

32. Amoxicillin/clavulanic-acid

    Case report 16 March 2024 Pages: 32 - 32

33. Amoxicillin/clavulanic-acid/clarithromycin/steroids

    Case report 16 March 2024 Pages: 33 - 33

34. Amoxicillin/clavulanic-acid/Diclofenac

    Case report 16 March 2024 Pages: 34 - 34

35. Amoxicillin/clavulanic-acid/Warfarin interaction

    Case report 16 March 2024 Pages: 35 - 35

36. Amphotericin B liposomal

    Case report 16 March 2024 Pages: 36 - 36

37. Amphotericin B liposomal/isavuconazole

    Case report 16 March 2024 Pages: 37 - 37

38. Amphotericin-B

    Case report 16 March 2024 Pages: 38 - 38

39. Amphotericin-B-liposomal

    Case report 16 March 2024 Pages: 39 - 39

40. Amphotericin-B-liposomal

    Case report 16 March 2024 Pages: 40 - 40

41. Amphotericin-B-liposomal

    Case report 16 March 2024 Pages: 41 - 41

42. Amphotericin-B/voriconazole

    Case report 16 March 2024 Pages: 42 - 42

43. Anastrozole/letrozole

    Case report 16 March 2024 Pages: 43 - 43

44. Anthracyclines/cytarabine/hydroxycarbamide

    Case report 16 March 2024 Pages: 44 - 44

45. Antibacterials/dexamethasone/remdesivir

    Case report 16 March 2024 Pages: 45 - 45

46. Antibacterials/immune-globulin

    Case report 16 March 2024 Pages: 46 - 46

47. Antiepileptic-drugs

    Case report 16 March 2024 Pages: 47 - 47

48. Antineoplastics

    Case report 16 March 2024 Pages: 48 - 48

49. Antineoplastics

    Case report 16 March 2024 Pages: 49 - 49

50. Antineoplastics

    Case report 16 March 2024 Pages: 50 - 50